HemoGenyx Pharmaceuticals Plc Stock Chart

HemoGenyx Pharmaceuticals Plc (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About HemoGenyx Pharmaceuticals Plc

LSE
Market Cap
£57.90M
Shares Out.
5.36M
Sector
Health Technology
Industry
Biotechnology

HemoGenyx Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of a suite of products to address current problems associated with the treatment of blood disorders such as cancers and autoimmune diseases, with bone marrow, or hematopoietic stem cell, transplants, and with viral infections. It operates through the United Kingdom and United States geographical segments. The company was founded by Alexis M. Sandler and Vladislav Sandler in 2012 and is headquartered in London, the United Kingdom.

hemogenyx.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
HEMO.GB (HEMO.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart